2023 ACR/EULAR AntiPhospholipid Syndrome Classification Criteria

Explore the newly developed 2023 ACR/EULAR classification criteria for AntiPhospholipid Syndrome (APS) in this informative 48-minute webinar presented by Professor Stéphane Zuily. Gain a critical overview of the criteria jointly supported by the American College of Rheumatology (ACR) and EULAR, designed for healthcare professionals specializing in vascular medicine and rare diseases. Delve into the management of common vascular diseases, including thrombosis, peripheral artery disease, aneurysms, and acrosyndrome, as well as rare conditions affecting arteries, veins, lymphatics, and microcirculation. Learn from Professor Zuily's expertise in thrombosis research, particularly in antiphospholipid syndrome, and his role as national investigator coordinator for the COVI-DOSE trial. Discover valuable insights into anticoagulant strategies for preventing thrombosis in COVID-19 patients. Access additional resources on APS and stay updated with the latest developments by registering for the ERN ReCONNET Newsletter.

2023 ACR/EULAR AntiPhospholipid Syndrome (APS) classification criteria